William P. Sheridan

SR VP - CMO, BioCryst Pharmaceuticals.

Companies

BioCryst PharmaceuticalsSR VP - CMO Jul 3, 2008 to Mar 14, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

BioCryst Pharmaceuticals BCRX37,954 shares²$303.1K at $7.99Mar 10, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 10, 2022Sold 1,400 shares at $17.64 of BioCryst Pharmaceuticals²
Mar 10, 2022Sold 159,739 shares at $16.87 of BioCryst Pharmaceuticals²
Mar 10, 2022Exercised options 148,302 shares at $3.22 of BioCryst Pharmaceuticals²
Dec 14, 2021Granted 35,000 shares of BioCryst Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioCryst Pharmaceuticals, SR VP - CMO
2
SEC EDGARBioCryst Pharmaceuticals shares after the filing of Mar 10, 2022
3
SEC EDGARForm 4 filed Dec 16, 2021